跳至主要内容
临床试验/NCT02303236
NCT02303236已完成不适用

Biological Markers Predicting Exercise Capacity in Heart Failure Patients Supported With a Continuous-flow Left Ventricular Assist Device.

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
1
主要终点
Biological markers

研究概览

简要总结

Establishing the association between biological markers and exercise capacity in continuous-flow left ventricular assist device patients.

详细描述

The aim of this study is to investigate if specific biological markers can predict exercise capacity in advanced heart failure patients supported with continuous-flow left ventricular assist device patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stable CF-LVAD patients.

排除标准

  • Unstable CF-LVAD patients.

结局指标

主要结局

Biological markers

时间窗: Blood sampling on study day and samples are subsequently stored frozen.

Analysis of blood will be carried out on all samples simultaneously, expected markers are pro-BNP, MRproANP, copeptin, Gal-3 and proADM.

次要结局

  • Exercise capacity(Examination on study day. Patients will only be followed on the day of the study. Exercise testing is performed as the last intervention on the study day.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Finn Gustafsson

MD, Ph.D

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验